U.S. FDA warns five companies over BMPEA stimulant in supplements

The U.S. Food and Drug Administration warned five companies to stop selling dietary supplements containing an unapproved stimulant known as beta-methylphenylethylamine, or BMPEA. Pieter Cohen, assistant professor of medicine at Cambridge Health Alliance, is quoted.

Read the full article